- Home
- GALT vs RGLS Comparison
GALT vs RGLS Comparison
Compare GALT & RGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- RGLS
- Stock Information
- Founded
- GALT 2000
- RGLS 2007
- Country
- GALT United States
- RGLS United States
- Employees
- GALT N/A
- RGLS N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- RGLS Biotechnology: Pharmaceutical Preparations
- Sector
- GALT Health Care
- RGLS Health Care
- Exchange
- GALT Nasdaq
- RGLS Nasdaq
- Market Cap
- GALT 86.0M
- RGLS N/A
- IPO Year
- GALT N/A
- RGLS 2012
- Fundamental
- Price
- GALT $1.35
- RGLS $7.87
- Analyst Decision
- GALT Hold
- RGLS Buy
- Analyst Count
- GALT 1
- RGLS 6
- Target Price
- GALT N/A
- RGLS $8.50
- AVG Volume (30 Days)
- GALT 177.8K
- RGLS 2.9M
- Earning Date
- GALT 05-19-2025
- RGLS 05-20-2025
- Dividend Yield
- GALT N/A
- RGLS N/A
- EPS Growth
- GALT N/A
- RGLS N/A
- EPS
- GALT N/A
- RGLS N/A
- Revenue
- GALT N/A
- RGLS N/A
- Revenue This Year
- GALT N/A
- RGLS N/A
- Revenue Next Year
- GALT N/A
- RGLS N/A
- P/E Ratio
- GALT N/A
- RGLS N/A
- Revenue Growth
- GALT N/A
- RGLS N/A
- 52 Week Low
- GALT $0.73
- RGLS $0.83
- 52 Week High
- GALT $3.41
- RGLS $8.20
- Technical
- Relative Strength Index (RSI)
- GALT 49.34
- RGLS 92.34
- Support Level
- GALT $1.26
- RGLS $7.80
- Resistance Level
- GALT $1.63
- RGLS $7.87
- Average True Range (ATR)
- GALT 0.12
- RGLS 0.26
- MACD
- GALT 0.02
- RGLS 0.36
- Stochastic Oscillator
- GALT 35.00
- RGLS 94.59
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.